Studies look at how genes affect antipsychotic drug response

Nov 09, 2006

Researchers at the University of Illinois at Chicago College of Pharmacy are attempting to discover how genes determine how well an antipsychotic medication works in adults and children and the side effects it will cause.

Risperidone, a popular "atypical" antipsychotic medication, is used to treat mental illnesses such as schizophrenia and bipolar disorder.

Jeffrey Bishop, assistant professor of pharmacy practice, is examining the effects of one gene, catechol-o-methyltransferase, on brain activity, cognition and symptom response to the drug.

The study is being done in adults who are experiencing their first episode of schizophrenia who are treated with risperidone for six weeks as part of UIC's First Episode Program.

"Allowing patients with schizophrenia an increased chance at medication response literally could change their lives," Bishop said.

"While we know a great deal about the pharmacology of antipsychotics like risperidone, there is still much to learn about their influence on cognition and brain function, as well as how genetics affect overall medication response," he said.

Bishop says the project will serve as a first step toward a comprehensive pharmacogenetic analysis of metabolic pathways affecting response to the drug. He was presented with an award for new investigators from the American College of Clinical Pharmacy for the project.

The UIC Center for Cognitive Medicine's First Episode Program, directed by Dr. John Sweeney, has been studying patients with first-episode schizophrenia for the past five years.

Bishop is also beginning a second project to study how risperidone may elevate prolactin levels and cause weight gain in children ages 8-18 who suffer from pediatric bipolar disorder. An increase in prolactin (a pituitary hormone that may affect bone development) or weight gain occurs in some but not all of these young patients.

"We are trying to determine if some kids are at a greater risk than others for these problems by analyzing genetic markers," Bishop said.

Bishop said if children are to receive long-term drug therapy, clinicians need to make sure they are appropriately monitored and treated as safely as possible.

"Understanding risperidone pharmacogenetics and whether some individuals are at a higher risk for side effects is an important step in this process," he said.

Risperidone is widely prescribed to treat bipolar disorder in children, accounting for half of all atypical antipsychotic prescriptions in pediatric psychiatry. Adverse drug effects, such as weight gain and the possibility of prolactin elevation, are often dose-limiting and affect medication compliance.

Source: University of Illinois at Chicago

Explore further: Inaccurate reporting jeopardizing clinical trials

Related Stories

Traffic emissions may pollute one in three Canadian homes

Apr 21, 2015

A trio of recently published studies from a team of University of Toronto engineers has found that air pollution could be spreading up to three times farther than thought—contributing to varying levels ...

Communication devices enable children with disabilities

Apr 08, 2015

An interdisciplinary group of Northeastern University students and faculty have combined their knowledge of engineering and physical therapy to design, develop, and then deliver two low-cost communication ...

Researchers use silk to cultivate organ tissues in the lab

Apr 02, 2015

Few organs in the body are as complicated as the human brain, a tight spiderweb of neurons that shoots electrical signals across synapses to control all our thoughts and movements. When something goes wrong—as ...

Fitness app connects exercisers to experts

Mar 24, 2015

Can advanced networking and next-generation applications help solve some of our nation's most pressing health problems? Can mobile devices and high-speed Internet be used to improve our health and well-being? ...

Recommended for you

Inaccurate reporting jeopardizing clinical trials

8 hours ago

The team led by Dr Sheena Cruickshank of the Faculty of Life Sciences and Professor Andy Brass from the School of Computer Science analysed 58 papers on research into inflammatory bowel disease published between 2000 and ...

Fat signals control energy levels in the brain

Apr 23, 2015

An enzyme secreted by the body's fat tissue controls energy levels in the brain, according to new research at Washington University School of Medicine in St. Louis. The findings, in mice, underscore a role ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.